Dr. Keith Crawford joined PHEN in 2019. As Director of Clinical Trials and Patient Education, he is responsible for implementing programs in these areas as well as working with patients and PHEN partners.
Dr. Crawford has more than 20 years of experience in the Life Sciences and completed his graduate and post-graduate training at Harvard Medical School where he developed competencies in the area of genomics, proteomics, immunology, microbiology, infectious diseases, and regenerative medicine.
During his post-doctoral training, Keith was selected by the Robert Wood Johnson Foundation as a Harold Amos Fellow. His work in the field of immunology caught the eye of the Department of Defense where he received funding to develop antidotes for chemical and biological weapons exposure as well as create a high throughput platform for the detection of biological weapons and emerging infectious agents.
After completing this directive, Dr. Crawford became the Director of the Center for Molecular Orthopedics at Brigham and Women’s Hospital. He was responsible for leading research efforts at the center, which gave rise to the discovery of a novel population of early lineage adult stem cells. Dr. Crawford and his colleagues were responsible for the preclinical studies, which laid the foundation for a spinal fusion therapeutic.
Dr. Crawford is a graduate of Prairie View University, the University of Texas Medical School in Houston (Medical Doctorate), and Harvard University (Doctor Philosophy) where he studied cell biology and immunology.
